Jon Jones mocked Daniel Cormier about steroid allegations prior to UFC 214 and now he is facing a drug suspension
Sean M. Haffey/Getty Images
The UFC has confirmed that Jon Jones is being investigated for a failed drug test on the night of his UFC 214 win over Daniel Cormier in which Jones reclaimed the light heavyweight title belt.
According to TMZ, Jones tested positive for Turinabol, an anabolic steroid and that he could be suspended for up to four years.
This would be the second time Jones has tested positive for steroids surrounding a UFC fight, following UFC 200 in 2016 in which he was pulled from the card just three days prior to the event. However, that is only part of the irony of his latest link to steroids.
Prior to UFC 214, Jones mocked Cormier on Twitter about previous steroid allegations, wondering aloud, "wonder what his excuse will be this time."
"Daniel says the only reason I defeated him the first time is because I must have been on steroids," Jones wrote on Twitter in July. "Wonder what his excuse will be this time."
Ouch. As Darren Rovell of ESPN noted, that tweet did not age well.
Daniel says the only reason I defeated him the first time is because I must have been on steroids, wonder what his excuse will be this time pic.twitter.com/HMCFQBoBR4
- Jon Bones Jones (@JonnyBones) July 21, 2017
- A centenarian who starts her day with gentle exercise and loves walks shares 5 longevity tips, including staying single
- A couple accidentally shipped their cat in an Amazon return package. It arrived safely 6 days later, hundreds of miles away.
- Colon cancer rates are rising in young people. If you have two symptoms you should get a colonoscopy, a GI oncologist says.
- Having an regional accent can be bad for your interviews, especially an Indian one: study
- Dirty laundry? Major clothing companies like Zara and H&M under scrutiny for allegedly fuelling deforestation in Brazil
- 5 Best places to visit near Darjeeling
- Climate change could become main driver of biodiversity decline by mid-century: Study
- RBI initiates transition plan: Small finance banks to ascend to universal banking status
- JNK India IPO allotment date
- JioCinema New Plans
- Realme Narzo 70 Launched
- Apple Let Loose event
- Elon Musk Apology
- RIL cash flows
- Charlie Munger
- Feedbank IPO allotment
- Tata IPO allotment
- Most generous retirement plans
- Broadcom lays off
- Cibil Score vs Cibil Report
- Birla and Bajaj in top Richest
- Nestle Sept 2023 report
- India Equity Market